KESTREL and KITE: 52-Week Results From Two Phase III Pivotal Trials of Brolucizumab for Diabetic Macular Edema

Autor: Brown, David M., Emanuelli, Andrés, Bandello, Francesco, Barranco, Jose Juan Escobar, Figueira, João, Souied, Eric, Wolf, Sebastian, Gupta, Vishali, Ngah, Nor Fariza, Liew, Gerald, Tuli, Raman, Tadayoni, Ramin, Dhoot, Dilsher, Wang, Lixin, Bouillaud, Emmanuel, Wang, Ying, Kovacic, Lidija, Guerard, Nicolas, Garweg, Justus G.
Zdroj: In American Journal of Ophthalmology June 2022 238:157-172
Databáze: ScienceDirect
Externí odkaz: